Published in West J Med on June 01, 1990
Kidney transplant revisited (1990) West J Med (1990) 0.75
The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature (1987) 12.43
Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science (1984) 8.01
Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol (1988) 4.05
Principles of solid-organ preservation by cold storage. Transplantation (1988) 3.79
Effect of blood transfusions on subsequent kidney transplants. Transplant Proc (1973) 3.42
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med (1989) 2.78
Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation (1985) 2.34
Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science (1988) 2.28
FK-506--how much potential? Immunol Today (1989) 2.20
Local use of kidneys with poor HLA matches is as good as shared use with good matches in the cyclosporine era: an analysis at one and two years. Transplant Proc (1987) 2.03
Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis (1985) 1.88
The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation (1988) 1.72
Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent. Am J Med (1988) 1.60
Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response. Lancet (1984) 1.57
Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation (1989) 1.50
Cyclosporine nephrotoxicity. Kidney Int (1986) 1.44
Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc (1988) 1.44
Granulocyte-associated immunoglobulins in renal transplant recipients with cytomegalovirus infection. Lancet (1988) 1.43
Duplex Doppler sonography of renal transplants: lack of sensitivity and specificity in establishing pathologic diagnosis. AJR Am J Roentgenol (1989) 1.41
Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet (1988) 1.41
Rapid identification of viral infections in liver, heart, and kidney allograft biopsies by in situ hybridization. Am J Surg Pathol (1989) 1.38
The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int (1988) 1.34
Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients. J Antimicrob Chemother (1986) 1.31
Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. N Engl J Med (1989) 1.29
The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int (1989) 1.28
Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation. Lancet (1989) 1.23
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity. Transplantation (1989) 1.23
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2. Transplantation (1989) 1.22
Improved kidney graft survival in nontransfused recipients. Transplant Proc (1987) 1.22
Sequential antilymphoblast globulin and cyclosporine for renal transplantation. Transplantation (1987) 1.16
Cancer development in patients progressing to dialysis and renal transplantation. Transplant Proc (1985) 1.14
Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation (1989) 1.12
Side effects of systemic cyclosporine in patients not undergoing transplantation. Am J Med (1984) 1.10
Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet (1986) 1.07
Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody. Transplantation (1983) 1.04
Immunologic diagnosis of kidney rejection using FACS analysis of graft-infiltrating functional and activated T and NK cell subsets. Transplantation (1989) 1.02
Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation (1989) 1.02
Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation (1987) 1.01
Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers. Kidney Int (1986) 1.01
Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients. Transplantation (1989) 1.00
Combined cold storage-perfusion preservation with a new synthetic perfusate. Transplantation (1989) 0.99
Total lymphoid irradiation--current status. Transplant Proc (1989) 0.99
Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation. Transplantation (1988) 0.98
Optimal use of organs for transplantation. N Engl J Med (1988) 0.97
Dominant effect of histocompatibility on ten-year kidney transplant survival. Transplantation (1988) 0.95
The human immune response to the OKT3 monoclonal antibody is oligoclonal. Science (1986) 0.95
The acquired immunodeficiency syndrome and transplantation. Transplantation (1987) 0.95
Prevention of rejection of kidney transplants by monoclonal antibody directed against interleukin 2. Lancet (1987) 0.95
The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation. Transplantation (1989) 0.95
Substantial benefits of tissue matching in renal transplantation. Transplantation (1987) 0.94
Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity. Kidney Int (1987) 0.92
Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function. Transplantation (1988) 0.92
Noncompliance in organ transplant recipients. Transplant Proc (1989) 0.92
Human immunodeficiency virus transmission by organ donation. Outcome in cornea and kidney recipients. Transplantation (1987) 0.92
Growth and endocrine function after renal transplantation. Arch Dis Child (1988) 0.92
Renal vascular and thrombotic effects of cyclosporine. Am J Kidney Dis (1989) 0.90
Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Transplantation (1988) 0.90
The effect of zero HLA class I and II mismatching in cyclosporine-treated kidney transplant patients. Transplantation (1987) 0.90
Successful five-day perfusion preservation of the canine kidney. Transplantation (1989) 0.90
The benefit of exchanging donor kidneys among transplant centers. N Engl J Med (1988) 0.90
Limitations of creatinine in quantifying the severity of cyclosporine-induced chronic nephropathy. Am J Kidney Dis (1986) 0.90
Renal transplantation of the infant and young child and the use of pediatric cadaver kidneys for transplantation in pediatric and adult recipients. Am J Kidney Dis (1988) 0.89
The influence of donor age on renal function in transplant recipients. Am J Kidney Dis (1988) 0.89
Benefits of removal of native kidneys in hypertension after renal transplantation. Lancet (1985) 0.89
Changes in facial appearance during cyclosporin treatment. Lancet (1987) 0.88
FK506: a novel immunosuppressive agent. Characteristics of binding and uptake by human lymphocytes. Transplantation (1988) 0.88
Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis (1988) 0.88
Inhibition of cytokine production by cyclosporine A and G. Transplantation (1989) 0.88
Psychiatric issues in renal dialysis and transplantation. Hosp Community Psychiatry (1983) 0.88
Withdrawal of steroid immunosuppression in renal transplant recipients. Transplantation (1988) 0.88
Anti-interleukin 2 receptor monoclonal antibody in the treatment of ongoing acute rejection episodes of human kidney graft--a pilot study. Transplantation (1989) 0.87
Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trial. Arch Surg (1988) 0.87
Participation of dendritic cells in vascular lesions of chronic rejection of human allografts. Lancet (1988) 0.86
Chronic injury of human renal microvessels with low-dose cyclosporine therapy. Transplantation (1988) 0.86
Cancer after transplantation. World J Surg (1986) 0.86
Ten-year results of renal transplantation with azathioprine and prednisolone as only immunosuppression. Lancet (1988) 0.86
Renal transplant patients treated with total lymphoid irradiation show specific unresponsiveness to donor antigens the mixed leukocyte reaction (MLR). J Immunol (1987) 0.86
Effect of combined anti-gamma interferon antibody and cyclosporine therapy on cardiac allograft survival in the rat. Transplantation (1988) 0.85
Serial decrease in glomerular filtration rate in long-term pediatric liver transplantation survivors treated with cyclosporine. Transplantation (1989) 0.85
Quality of life after kidney transplantation. A prospective, randomized comparison of cyclosporine and conventional immunosuppressive therapy. Transplantation (1988) 0.85
Cancer incidence in renal transplant patients treated with azathioprine or cyclosporine. Transplant Proc (1987) 0.85
Improved immediate function of renal allografts with Belzer perfusate. Transplantation (1988) 0.85
A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients. Transplantation (1989) 0.85
The late results of renal transplantation and the importance of chronic rejection as a cause of graft loss. Ann R Coll Surg Engl (1989) 0.84
Evidence of involvement of tumor necrosis factor in adverse reactions during treatment of kidney allograft rejection with antithymocyte globulin. Transplantation (1989) 0.84
Stability of renal allograft function associated with long-term cyclosporine immunosuppressive therapy--five year follow-up. Transplantation (1989) 0.84
Prospects for the clinical management of human cytomegalovirus infections. Vaccine (1986) 0.83
Cyclosporine plasma levels six hours after oral administration. A useful tool for monitoring therapy. Transplantation (1988) 0.83
Reexposure to OKT3 in renal allograft recipients. Transplantation (1988) 0.83
Cadaveric renal transplantation with cyclosporine in patients more than 60 years of age. Transplantation (1989) 0.83
Cellular infiltrates in allografts. Transplant Proc (1987) 0.83
Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity. Transplantation (1987) 0.83
Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies. Transplantation (1988) 0.82
Recurrence of disease following renal transplantation. Am J Kidney Dis (1988) 0.82
Inability of cyclosporine to completely prevent the recurrence of focal glomerulosclerosis after kidney transplantation. Transplantation (1989) 0.82
Incidental and purposeful random donor blood transfusion. Sensitization and transplantation. Transplantation (1989) 0.82
Hypertension after renal transplantation. A comparison of cyclosporine and conventional immunosuppression. Transplantation (1987) 0.82
Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene (2009) 3.09
Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis (1993) 1.87
Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood (2000) 1.76
Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response. Lancet (1984) 1.57
Short-term responsiveness of membranous glomerulopathy to cyclosporine. Am J Kidney Dis (1992) 1.46
The cellular basis of cardiac allograft rejection: VIII. Mechanisms underlying delayed allograft rejection in PVG C6-deficient rats. Transplantation (1998) 1.40
Stat3 activation in human endometrial and cervical cancers. Br J Cancer (2007) 1.31
Cells mediating allograft rejection. Immunol Rev (1984) 1.31
The cellular basis of allograft rejection in vivo. I. The cellular requirements for first-set rejection of heart grafts. J Exp Med (1978) 1.30
Distribution of mercury resistance among Staphylococcus aureus isolated from a hospital community. J Hyg (Lond) (1970) 1.23
Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. J Exp Med (1985) 1.21
The cellular basis of allograft rejection in vivo. II. The nature of memory cells mediating second set heart graft rejection. J Exp Med (1978) 1.11
Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody. Transplantation (1993) 1.11
Expression of leucocyte and lymphocyte adhesion molecules in the human kidney. Kidney Int (1989) 1.10
Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivo. J Med Genet (2005) 1.05
The cellular basis of allograft rejection in vivo. III. Restoration of first-set rejection of heart grafts by T helper cells in irradiated rats. Transplantation (1983) 1.03
Microvascular destruction in renal transplant rejection. Transplantation (1989) 1.02
Evaluation of subclinical depression in children using self-, peer-, and teacher-report measures. J Abnorm Child Psychol (1990) 1.02
Role of T cells in the mediation of Heymann nephritis. ii. Identification of Th1 and cytotoxic cells in glomeruli. Kidney Int (1997) 1.02
Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers. Kidney Int (1986) 1.01
Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell. J Exp Med (1985) 0.99
Suppressor T cells in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Transplantation (1984) 0.99
Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4. Int Immunol (2001) 0.96
The effects of whole body irradiation on serum colony stimulating factor and in vitro colony-forming cells in the bone marrow. Br J Haematol (1969) 0.95
Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells. J Immunol (1989) 0.95
Mercury resistance of Staphylococcus aureus. J Hyg (Lond) (1970) 0.94
Hereditary C6 deficiency in a strain of PVG/c rats. Clin Exp Immunol (1994) 0.93
Expression of HLA antigens on renal tubular cells in culture. II. Effect of increased HLA antigen expression on tubular cell stimulation of lymphocyte activation and on their vulnerability to cell-mediated lysis. Transplantation (1988) 0.92
Magnitude of memory to the major histocompatibility complex. Nature (1977) 0.91
A6--a new 45RO monoclonal antibody for immunostaining of paraffin-embedded tissues. Am J Clin Pathol (1991) 0.90
Active Heymann nephritis in complement component C6 deficient rats. Kidney Int (1995) 0.90
Mechanisms of specific unresponsiveness to allografts. Transplant Proc (1984) 0.89
Induction of tolerance to heart allografts in rats using posttransplant total lymphoid irradiation and anti-T cell antibodies. Transplantation (1993) 0.89
The role of T cells in the mediation of glomerular injury in Heymann's nephritis in the rat. Int Immunol (1992) 0.89
Fecal androgens of bison bulls during the rut. Horm Behav (2004) 0.89
Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses. Transplantation (1998) 0.88
Presence of methylated adenine in GATC sequences in chromosomal DNAs from Campylobacter species. J Bacteriol (1992) 0.88
Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with TH2 cytokines not anergy. Transplantation (1999) 0.87
Lymphocyte subsets in Heymann nephritis. Lab Invest (1984) 0.87
Glucocorticoids of bison bulls in relation to social status. Horm Behav (2005) 0.86
Ovarian function after renal transplantation: comparison of cyclosporin A with azathioprine and prednisone combination regimens. Br J Obstet Gynaecol (1984) 0.86
Expression of HLA antigens on renal tubular cells in culture. I. Evidence that mixed lymphocyte culture supernatants and gamma interferon increase both class I and class II HLA antigens. Transplantation (1986) 0.86
Renal biopsy morphology in renal transplantation. A comparative study of the light-microscopic appearances of biopsies from patients treated with cyclosporin A or azathioprine prednisone and antilymphocyte globulin. Am J Surg Pathol (1984) 0.86
Cancer incidence in renal transplant patients treated with azathioprine or cyclosporine. Transplant Proc (1987) 0.85
The regulation of autoantibody production in Heymann's nephritis by T lymphocyte subsets. Lab Invest (1988) 0.85
A monoclonal antibody (A6) recognizing a unique epitope restricted to CD45RO and RB isoforms of the leukocyte common antigen family identifies functional T cell subsets. Cell Immunol (1994) 0.84
Permanent CD8(+) T cell depletion prevents proteinuria in active Heymann nephritis. J Exp Med (1998) 0.84
A model for study of the cellular mechanisms that maintain long-term enhancement of cardiac graft survival. Transplant Proc (1979) 0.83
CD4(+), CD25(+) T cells as regulators of alloimmune responses. Transplant Proc (2001) 0.83
Cellular infiltrates in allografts. Transplant Proc (1987) 0.83
Induction of HLA-DR antigens on cultured human kidney cells. Transplant Proc (1986) 0.82
Mycophenolate mofetil prevents the induction of active Heymann nephritis: association with Th2 cytokine inhibition. J Am Soc Nephrol (1998) 0.82
Composition of the milk of the common marmoset (Callithrix jacchus) and milk substitutes used in hand-rearing programmes, with special reference to fatty acids. Folia Primatol (Basel) (1978) 0.81
A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: the use of monoclonal antibodies and double immunolabeling. Hepatology (1990) 0.81
Induction of unresponsiveness to Heymann's nephritis: inhibited by monoclonal antibody to CD4 but not to CD8. Cell Immunol (1991) 0.81
Stimulation of renin release from rat renal cortical slices by cyclosporin A. Res Commun Chem Pathol Pharmacol (1984) 0.81
Effects of immunosuppressive drugs on functions of activated T lymphocytes. Cyclosporine inhibition of gamma interferon production in the presence of interleukin. Transplantation (1988) 0.80
Lymphocyte adhesion molecules in T cell-mediated lysis of human kidney cells. Kidney Int (1991) 0.80
Il-4 therapy prevents the development of proteinuria in active Heymann nephritis by inhibition of Tc1 cells. J Immunol (2001) 0.80
Induction of tolerance with nondepleting anti-CD4 monoclonal antibodies is associated with down-regulation of TH2 cytokines. Transplantation (1997) 0.80
Interleukin 12 delays allograft rejection: effect mediated via nitric oxide. Transplant Proc (2001) 0.79
IL-5 prolongs allograft survival by downregulating IL-2 and IFN-gamma cytokines. Transplant Proc (2001) 0.79
Threshold for occluded formaldehyde patch test in formaldehyde-sensitive patients. Relationship to repeated open application test with a product containing formaldehyde releaser. Contact Dermatitis (1997) 0.79
The possible role of cytotoxic T cells in the mediation of first-set allograft rejection. Transplantation (1985) 0.78
Memory T cells express high levels of a novel leukocyte common antigen epitope identified by the A6 MAb. Transplant Proc (1991) 0.78
"The factor of immunization" in allograft rejection: carried by cytotoxic T cells, not helper-inducer T cells. Transplant Proc (1986) 0.78
Metabolism of essential fatty acids in the human fetus and neonate. Nutr Metab (1977) 0.78
Interstitial fibrosis in renal allografts in patients treated with cyclosporin. Lancet (1984) 0.78
Treatment of renal transplantation rejection. Cyclosporin A versus conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in primary cadaveric renal transplantation. Med J Aust (1985) 0.78
Influence of cyclosporine A (CSA) on intrarenal control of GFR. Clin Nephrol (1986) 0.78
Identification of the cellular subpopulations infiltrating rejecting cadaver renal allografts. Preponderance of the T4 subset of T cells. Transplantation (1984) 0.78
The cellular basis of the maintenance of passive enhancement. Transplant Proc (1981) 0.78
Cyclosporin A and renal prostaglandin biosynthesis. Res Commun Chem Pathol Pharmacol (1984) 0.78
Recombinant interferon alpha and hemolytic uremic syndrome: cause or coincidence? Am J Hematol (1994) 0.78
Immunosuppression in renal transplantation. Med J Aust (1982) 0.78
Protective effects of transgenic human endothelial protein C receptor expression in murine models of transplantation. Am J Transplant (2012) 0.78
Diagnosis of renal allograft rejection by analysis of fine-needle aspiration biopsy specimens with immunostains and simple cytology. Lancet (1986) 0.77
Renal tubular transport of cyclosporine A (CSA) and associated changes in renal function. Clin Nephrol (1986) 0.77
Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. V. Dependence of CD4+ suppressor cells on the presence of alloantigen and cytokines, including interleukin 2. Transplantation (1993) 0.77
Testicular function after renal transplantation: comparison of Cyclosporin A with azathioprine and prednisone combination regimes. Clin Nephrol (1984) 0.76
Peripheral neuropathy complicating primary hyperoxaluria. J Neurol Sci (1976) 0.76
Cyclosporin A-induced increases in renin storage and release. Res Commun Chem Pathol Pharmacol (1982) 0.76
Role of the spleen in cell-mediated cardiac allograft rejection. Transplantation (1982) 0.76
Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine. Kidney Int (1985) 0.76
Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. IV. Examination of T cell subsets in graft-versus-host assays. Transplantation (1990) 0.76
Detection of a late lymphocyte activation marker by A1, a new monoclonal antibody. Transplant Proc (1988) 0.76
Effect of antihypertensive drugs on neonatal blood pressure. Clin Exp Pharmacol Physiol (1985) 0.75
Specific unresponsiveness to allografts induced by cyclosporine is not antibody dependent. Transplant Proc (1985) 0.75
Cardiac allograft vascular disease. Relationship to microvascular cell surface markers and inflammatory cell phenotypes on endomyocardial biopsy. Circulation (1995) 0.75
Immunology of renal transplantation rejection. Med J Aust (1982) 0.75
Use of monoclonal antibodies to study in vivo and in vitro-activated lymphocytes. Transplant Proc (1989) 0.75
Transplantation of kidneys from living related donors in Australia. Med J Aust (1984) 0.75
Hypertension in pregnancy. A study of 142 women presenting before 32 weeks' gestation. Med J Aust (1985) 0.75
Assessment of fine needle aspiration biopsies from renal transplants using monoclonal antibodies as lymphocyte markers. Transplant Proc (1986) 0.75
Transplantation in Australia and New Zealand. Transplant Proc (1984) 0.75
Comparison of CD4 and CD8 T cell reactivity in high-responder and low-responder strain combinations in the rat. Transplant Proc (1989) 0.75
Renal disease in systemic lupus erythematosus. Med J Aust (1984) 0.75
Expression of adhesion molecules by human renal tubular cells in culture and binding of activated lymphocytes. Transplant Proc (1989) 0.75
T cell subsets mediating lethal graft versus host disease: demonstration that synergy between CD4+ and CD8+ T cells is the predominant mechanism in low responder rat strains. Cell Immunol (1989) 0.75